Epigenomics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.4%.

Top 17 shareholders own 48.72% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
14.4%	Deutsche Balaton AG	588,455	US$398.9k	0%	0.39%
5.57%	Heidelberger Beteiligungsholding AG, Asset Management Arm	228,111	US$154.6k	0%	14.32%
5.09%	Markus Pfitzke	208,203	US$141.2k	640%	no data
5.07%	Altium Capital Management LP	207,338	US$140.6k	0%	0.09%
4.54%	ABC Beteiligungen AG	185,700	US$125.9k	0%	no data
3.84%	DELPHI Unternehmensberatung Aktiengesellschaft	157,001	US$106.4k	0%	no data
3.33%	2invest AG	136,228	US$92.4k	0%	no data
2.63%	Bridger Management LLC	107,671	US$73.0k	0%	0.03%
2.59%	Axel Sartingen	106,023	US$71.9k	0%	no data
1.02%	Heino von Prondzynski	41,565	US$28.2k	0%	no data
0.56%	Wilhelm Zours	23,003	US$15.6k	0%	no data
0.07%	Alexander Link	2,873	US$1.9k	0%	no data
0.016%	Gregory Hamilton	664	US$450.1	0%	no data
0.015%	Franz Walt	609	US$412.9	0%	no data
0.013%	Helge Lubenow	548	US$371.5	0%	no data
0.002%	FPS Vermögensverwaltung	82	US$55.5	0%	no data
0.00007%	Albert Weber	3	US$1.9	0%	no data